Skip to main content

Table 3 Changes of COPD assessment test (CAT) score after therapy (N = 52)

From: Therapeutic effect of budesonide/formoterol, montelukast and N-acetylcysteine for bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation

Clinical variable

BOS diagnosis

3 months treatment

P-value

Q1. Cough

1.5 (0–2)

1 (0–2)

.022

Q2. Phlegm

1 (0–2)

1 (0–2)

.983

Q3. Chest tightness

2 (1–3)

1 (0–2)

.000

Q4. Breathlessness going up hills/stairs

3 (2–4)

3 (1.25-3)

.002

Q5. Activity limitation at home

1 (0–2)

0 (0–1)

.054

Q6. Confidence leaving home

1 (0–3)

1 (0–2)

.013

Q7. Sleep

2 (1–3)

1 (0–2.75)

.004

Q8. Energy

2 (2–3)

2 (1–3)

.035

Total sum of the eight items

15.5 (9.25–19.0)

11.0 (6.0–15.75)

.001

  1. Data represent the median (IQR). P-values shown in bold are significant at the 0.05 level